• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌肝切除术后的长期存活者

Long-term survivors after hepatectomy for hepatocellular carcinoma.

作者信息

Tsunoda T, Segawa T, Eto T, Izawa K, Tsuchiya R

机构信息

Second Department of Surgery, Nagasaki University School of Medicine, Japan.

出版信息

J Gastroenterol Hepatol. 1990 Nov-Dec;5(6):595-600. doi: 10.1111/j.1440-1746.1990.tb01112.x.

DOI:10.1111/j.1440-1746.1990.tb01112.x
PMID:1966595
Abstract

Sixteen long-term (more than 5 years) survivors after hepatic resection performed for hepatocellular carcinoma (HCC) from 1970 to 1988, were reviewed. The mean age of the patients was 51 years. There were 11 males and 5 females. HBs antigen was positive in 9 patients. Liver cirrhosis was associated with 11 patients but its severity was designated as Child's A in all patients except one. The mean tumour diameter was 2.8 cm and was relatively small. At the first operation, limited procedures (i.e. partial hepatectomy and subsegmentectomy) were employed in 87.5% of patients. A large percentage of tumours were located in S5 and S6 segments. A recurrence of HCC occurred in 9 patients after the first resection. A second resection was carried out in 7 patients, in 2 of which a third resection was done. Transcatheter arterial embolization (TAE) was performed on 4 patients. These results show that, in addition to detection of small tumours and early resection, repeated operation or TAE for treatment of recurrent HCC was important in achieving long-term survival after HCC resection.

摘要

对1970年至1988年期间因肝细胞癌(HCC)接受肝切除术后存活16例长期(超过5年)的患者进行了回顾性研究。患者的平均年龄为51岁。男性11例,女性5例。9例患者乙肝表面抗原呈阳性。11例患者伴有肝硬化,但除1例患者外,所有患者的肝硬化严重程度均为Child A级。肿瘤平均直径为2.8 cm,相对较小。首次手术时,87.5%的患者采用了有限手术(即肝部分切除术和肝段下切除术)。大部分肿瘤位于S5和S6段。9例患者首次切除术后发生HCC复发。7例患者进行了二次切除,其中2例进行了三次切除。4例患者接受了经导管动脉栓塞术(TAE)。这些结果表明,除了发现小肿瘤和早期切除外,对复发性HCC进行重复手术或TAE治疗对于HCC切除术后实现长期生存很重要。

相似文献

1
Long-term survivors after hepatectomy for hepatocellular carcinoma.肝细胞癌肝切除术后的长期存活者
J Gastroenterol Hepatol. 1990 Nov-Dec;5(6):595-600. doi: 10.1111/j.1440-1746.1990.tb01112.x.
2
[Evaluation of hepatectomy in small hepatocellular carcinoma--comparison with transcatheter arterial embolization therapy].小肝细胞癌肝切除术的评估——与经导管动脉栓塞治疗的比较
Nihon Geka Gakkai Zasshi. 1992 Sep;93(9):1095-9.
3
Repeat hepatic resection for recurrent hepatocellular carcinoma.
Hepatogastroenterology. 1993 Aug;40(4):337-41.
4
Subsegmentectomy or segmentectomy in hepatocellular carcinoma.肝细胞癌的亚肝段切除术或肝段切除术。
Hepatogastroenterology. 1998 Jan-Feb;45(19):2-6.
5
Longterm prognosis after hepatic resection for small hepatocellular carcinoma.小肝细胞癌肝切除术后的长期预后
J Am Coll Surg. 2004 Mar;198(3):356-65. doi: 10.1016/j.jamcollsurg.2003.10.017.
6
[A case of long-term survival with TAE resistant multiple recurrence HCC successfully treated by hepatic resection].[经肝切除成功治疗对肝动脉栓塞化疗耐药的多次复发性肝癌并长期生存1例]
Gan To Kagaku Ryoho. 2003 Oct;30(11):1717-21.
7
Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.中国单中心经验:复发性肝细胞癌患者再次肝切除的长期结果及复发类型分析和其预后。
Ann Surg Oncol. 2012 Aug;19(8):2515-25. doi: 10.1245/s10434-012-2269-7. Epub 2012 Mar 7.
8
[Recurrent hepatocellular carcinoma after hepatic resection].
Nihon Geka Gakkai Zasshi. 1992 Jul;93(7):723-30.
9
Management of spontaneous bleeding due to hepatocellular carcinoma.肝细胞癌所致自发性出血的管理
Minerva Chir. 2002 Jun;57(3):347-56.
10
Prognostic factors in resected hepatocellular carcinomas and therapeutic value of transcatheter arterial embolization for recurrences.手术切除的肝细胞癌的预后因素及经动脉导管栓塞术对复发的治疗价值。
Int Surg. 1998 Apr-Jun;83(2):146-9.

引用本文的文献

1
Operative results in 143 patients with hepatocellular carcinoma.
World J Surg. 1993 Sep-Oct;17(5):663-7; discussion 668. doi: 10.1007/BF01659138.
2
Five-year survival after transcatheter chemoembolization for hepatocellular carcinoma.
Cancer Chemother Pharmacol. 1994;33 Suppl:S89-92. doi: 10.1007/BF00686675.